Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options

A Sterkens, J Lambert, A Bervoets - Clinical and experimental medicine, 2021 - Springer
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete
scalp, including eyelashes and eyebrows, or even the entire body. The exact pathology is …

Drug discovery for alopecia: gone today, hair tomorrow

Z Santos, P Avci, MR Hamblin - Expert opinion on drug discovery, 2015 - Taylor & Francis
Introduction: Hair loss or alopecia affects the majority of the population at some time in their
life, and increasingly, sufferers are demanding treatment. Three main types of alopecia …

Alopecia areata–Current understanding and management

DA Lintzeri, A Constantinou, K Hillmann… - JDDG: Journal der …, 2022 - Wiley Online Library
Alopecia areata (AA) is a chronic, immune‐mediated disease characterized by acute or
chronic non‐scarring hair loss, with a heterogeneity in clinical manifestations ranging from …

Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial

TD Horn, SM Johnson, RM Helm… - Archives of …, 2005 - jamanetwork.com
Background Warts occur commonly in humans. Destructive modalities are generally the first
physician-administered therapy. Other treatment options include immunotherapy …

[图书][B] Pediatric Dermatology E-Book: Expert Consult-Online and Print, 2-Volume Set

LA Schachner, RC Hansen - 2011 - books.google.com
The latest edition of Pediatric Dermatology, edited by Lawrence A. Schachner, MD and
Ronald C. Hansen, MD brings you the detailed guidance you need to effectively diagnose …

Application of topical immunotherapy in the treatment of alopecia areata: a review and update

T Mahasaksiri, C Kositkuljorn… - Drug design …, 2021 - Taylor & Francis
Abstract Treatment of extensive or recalcitrant alopecia areata (AA) is a major clinical
challenge. Even after thorough investigation of several medications, its treatment outcomes …

Treatment of cutaneous warts: an evidence-based review

F Dall'Oglio, V D'Amico, MR Nasca, G Micali - American journal of clinical …, 2012 - Springer
Cutaneous warts are common skin lesions caused by human papillomavirus infection.
Treatment is aimed at relieving the patient's physical and psychological discomfort and at …

Resin monomer 2-hydroxyethyl methacrylate (HEMA) is a potent inducer of apoptotic cell death in human and mouse cells

A Paranjpe, LCF Bordador, M Wang… - Journal of dental …, 2005 - journals.sagepub.com
Mechanisms by which the resin monomer 2-hydroxyethyl methacrylate (HEMA) induces
hypersensitivity reactions in humans are not well-established, nor have the direct effects of …

Pulsed dye laser treatment for viral warts: a study of 120 patients

HS Park, WS Choi - The Journal of Dermatology, 2008 - Wiley Online Library
ABSTRACT A prospective, non‐blinded, non‐randomized study on 120 wart patients treated
with pulsed dye laser was performed to evaluate the efficacy and safety of pulsed dye laser …

Two‐year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts

CH Na, H Choi, SH Song, MS Kim… - Clinical and …, 2014 - academic.oup.com
Background The currently available treatments for warts, including cryosurgery, laser
surgery, electrosurgery, and topical keratolytic applications, are often very painful and can …